Original Article
Comparative assessment of pharmacokinetic parameters between HS016, an adalimumab biosimilar, and adalimumab (Humira®) in healthy subjects and ankylosing spondylitis patients: Population pharmacokinetic modeling
Xiaofeng Zeng, Jing Zhang, Jicheng Yu, Xiaojie Wu, Yuancheng Chen, Jufang Wu, Xiaoli Yang, Jingjing Wang, Guoying Cao
499-509